Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-Pep-12
- Development stage
- Unknown
- Lead developer
- EVER Pharma
- Modality
- Peptides
- Administration
- Oral
01
Overview
Cebrium (N-Pep-12) is a peptide-based nutritional supplement developed by EVER Pharma for the management of light, age-related memory problems and the support of cognitive function. The active ingredient, N-Pep-12, is a biotechnologically prepared mixture of neuropeptides and amino acids derived from purified porcine brain tissue through enzymatic cleavage. It is designed to support neurotransmission and protect neuronal health, thereby improving concentration and mental performance in adults experiencing cognitive decline or intellectual stress. It is typically administered orally as a once-daily capsule.
- Brand names
- CebriumMemoProve
- Other names
- porcine brain peptide complexpeptone
Beyond the preview
Go deeper on N-Pep-12.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on N-Pep-12.